Bios Equity COF, LP

Insider Reports History

Location
Fort Worth, TX
Signature
Bios Equity COF, LP By: Bios Capital Management, LP, its general partner By: Bios Advisors GP, LLC, its general partner By: /s/ John Fucci, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bios Equity COF, LP:

Company Role Class Num Shares Value Price $ Report Date Ownership
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 2,506,667 $23,086,403 $9.21 27 Jun 2025 Directly held by Bios Fund III QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 2,094,650 $19,291,726 $9.21 27 Jun 2025 Directly held by Bios Actuate Co-Invest II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 1,259,427 $11,599,322 $9.21 27 Jun 2025 Directly held by Bios Clinical Opportunity Fund, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 980,433 $9,029,787 $9.21 27 Jun 2025 Directly held by Bios Fund II QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 573,394 $5,280,958 $9.21 27 Jun 2025 Directly held by Bios Actuate Co-Invest III, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 525,797 $4,842,590 $9.21 27 Jun 2025 Directly held by Bios Fund I, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 404,814 $3,728,336 $9.21 27 Jun 2025 Directly held by Bios Fund III NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 383,791 $3,534,715 $9.21 27 Jun 2025 Directly held by Bios Fund III, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 307,538 $2,832,424 $9.21 27 Jun 2025 Directly held by Bios Fund I QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 300,749 $2,769,898 $9.21 27 Jun 2025 Directly held by Bios Actuate Co-Invest I, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 300,143 $2,764,317 $9.21 27 Jun 2025 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 196,428 $1,374,996 $7.00 27 Jun 2025 Directly held by Bios 2024 Co-Invest, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 131,248 $1,208,794 $9.21 27 Jun 2025 Directly held by Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 84,917 $782,085 $9.21 27 Jun 2025 Directly held by BP Directors, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 69,375 $638,943 $9.21 27 Jun 2025 Directly held by Circle K Invesco, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 60,973 $561,561 $9.21 27 Jun 2025 Directly held by Aaron G.L. Fletcher
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 8,056 $74,195 $9.21 27 Jun 2025 Directly held by KF Legacy Trust U/A/D December 7, 2016
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 8,056 $74,195 $9.21 27 Jun 2025 Directly held by MF Legacy Trust U/A/D December 7, 2016
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Warrant (Right to Buy) 71,428 27 Jun 2025 Directly held by Bios 2024 Co-Invest, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Stock Options 31,884 12 Aug 2024 Directly held by BP Directors, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Stock Options 15,000 12 Aug 2024 Directly held by Aaron G.L. Fletcher
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Convertible Note 0 14 Aug 2024 Directly held by Bios Clinical Opportunity Fund, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series A Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund I, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series A Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund I QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-1 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Actuate Co-Invest I, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-1 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-1 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-1 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund II QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-2 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Actuate Co-Invest I, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-2 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-2 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-2 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund II QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-3 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-3 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-3 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund II QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-4 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Actuate Co-Invest II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-4 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund III, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-4 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund III NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-4 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund III QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series C Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Actuate Co-Invest III, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series C Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund III, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series C Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund III NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series C Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund III QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Warrant (Right to Buy) 0 14 Aug 2024 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Warrant (Right to Buy) 0 14 Aug 2024 Directly held by Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Warrant (Right to Buy) 0 14 Aug 2024 Directly held by Bios Fund II QP, LP

Insider Reports Filed by Bios Equity COF, LP

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACTU ACTUATE THERAPEUTICS, INC. 27 Jun 2025 2 +$499,996 4 Director, 10%+ Owner 30 Jun 2025, 13:03
ACTU ACTUATE THERAPEUTICS, INC. 12 Aug 2024 3 -$199,992 4/A Director, 10%+ Owner 20 Aug 2024, 20:46